Pfizer PE Ratio 2006-2020 | PFE

Current and historical p/e ratio for Pfizer (PFE) from 2006 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Pfizer PE ratio as of August 04, 2020 is 13.33.
Pfizer PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-08-04 38.39 20.10
2020-06-30 32.70 $1.91 17.12
2020-03-31 32.64 $2.80 11.66
2019-12-31 39.18 $2.87 13.65
2019-09-30 35.93 $2.86 12.56
2019-06-30 43.32 $2.19 19.78
2019-03-31 42.47 $1.95 21.78
2018-12-31 43.28 $1.86 23.27
2018-09-30 43.36 $3.95 10.98
2018-06-30 35.39 $3.73 9.49
2018-03-31 34.29 $3.59 9.55
2017-12-31 34.68 $3.51 9.88
2017-09-30 33.87 $1.62 20.91
2017-06-30 31.56 $1.36 23.21
2017-03-31 31.84 $1.18 26.98
2016-12-31 29.92 $1.16 25.80
2016-09-30 30.90 $1.13 27.34
2016-06-30 31.85 $1.26 25.28
2016-03-31 26.57 $1.35 19.68
2015-12-31 28.65 $1.24 23.10
2015-09-30 27.65 $1.33 20.79
2015-06-30 29.28 $1.41 20.77
2015-03-31 30.13 $1.44 20.93
2014-12-31 26.75 $1.42 18.84
2014-09-30 25.17 $1.62 15.54
2014-06-30 25.04 $1.59 15.75
2014-03-31 26.86 $3.12 8.61
2013-12-31 25.40 $3.14 8.09
2013-09-30 23.64 $3.60 6.57
2013-06-30 22.86 $3.64 6.28
2013-03-31 23.36 $2.09 11.18
2012-12-31 20.12 $1.95 10.32
2012-09-30 19.76 $1.29 15.32
2012-06-30 18.12 $1.34 13.52
2012-03-31 17.67 $1.24 14.25
2011-12-31 16.71 $1.28 13.06
2011-09-30 13.52 $1.45 9.32
2011-06-30 15.58 $1.08 14.43
2011-03-31 15.21 $1.06 14.35
2010-12-31 12.98 $1.03 12.60
2010-09-30 12.60 $0.77 16.36
2010-06-30 10.35 $1.09 9.49
2010-03-31 12.32 $1.12 11.00
2009-12-31 12.94 $1.27 10.19
2009-09-30 11.66 $1.21 9.64
2009-06-30 10.46 $1.12 9.34
2009-03-31 9.39 $1.19 7.89
2008-12-31 11.95 $1.20 9.96
2008-09-30 12.21 $1.58 7.73
2008-06-30 11.38 $1.35 8.43
2008-03-31 13.42 $1.12 11.98
2007-12-31 14.37 $1.19 12.08
2007-09-30 15.26 $2.09 7.30
2007-06-30 15.78 $2.44 6.47
2007-03-31 15.43 $2.59 5.96
2006-12-31 15.65 $2.67 5.86
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $213.250B $51.750B
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $387.604B 18.47
Roche Holding AG (RHHBY) Switzerland $300.169B 0.00
Merck (MRK) United States $206.143B 14.74
Novartis AG (NVS) Switzerland $192.594B 14.97
Novo Nordisk (NVO) Denmark $152.191B 25.34
Eli Lilly (LLY) United States $148.109B 22.61
AstraZeneca (AZN) United Kingdom $147.175B 28.61
AbbVie (ABBV) United States $139.242B 10.14
Sanofi (SNY) $129.689B 15.41
GlaxoSmithKline (GSK) United Kingdom $103.451B 13.57
Bayer (BAYRY) Germany $62.742B 9.04
H Lundbeck (HLUYY) Denmark $7.279B 12.65
Innoviva (INVA) United States $1.362B 6.52